Interdialytic Weight Gain Effects on Hemoglobin Concentration and Cardiovascular Events

Grunze, 1990, Mechanisms of improved physical performance of chronic hemodialysis patients after erythropoietin treatment, Am J Nephrol, 10, 15, 10.1159/000168211 McMahon, 1999, Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patients, Nephrol Dial Transplant, 14, 1182, 10.1093/ndt/14.5.1182 Moreno, 2000, Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology, J Am Soc Nephrol, 11, 335, 10.1681/ASN.V112335 Kalantar-Zadeh, 2001, Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis, J Am Soc Nephrol, 12, 2797, 10.1681/ASN.V12122797 Li, 2004, Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients, Kidney Int, 65, 626, 10.1111/j.1523-1755.2004.00425.x Locatelli, 2004, Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Nephrol Dial Transplant, 19, 121, 10.1093/ndt/gfg458 Pisoni, 2004, Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Am J Kidney Dis, 44, 94, 10.1053/j.ajkd.2004.03.023 Robinson, 2005, Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time, Kidney Int, 68, 2323, 10.1111/j.1523-1755.2005.00693.x Regidor, 2006, Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients, J Am Soc Nephrol, 17, 1181, 10.1681/ASN.2005090997 Walker, 2006, Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine, J Am Soc Nephrol, 17, 2293, 10.1681/ASN.2005020183 Akizawa, 2008, Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS, Nephrol Dial Transplant, 23, 3643, 10.1093/ndt/gfn346 Akizawa, 2014, Low hemoglobin levels and hypo-responsiveness to erythropoiesis-stimulating agent associated with poor survival in incident Japanese hemodialysis patients, Ther Apher Dial, 18, 404, 10.1111/1744-9987.12155 Johansen, 2012, Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients, Nephrol Dial Transplant, 27, 2418, 10.1093/ndt/gfr697 Besarab, 1998, The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin, N Engl J Med, 339, 584, 10.1056/NEJM199808273390903 Parfrey, 2005, Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease, J Am Soc Nephrol, 16, 2180, 10.1681/ASN.2004121039 Singh, 2006, Correction of anemia with epoetin alfa in chronic kidney disease, N Engl J Med, 355, 2085, 10.1056/NEJMoa065485 Phrommintikul, 2007, Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis, Lancet, 369, 381, 10.1016/S0140-6736(07)60194-9 Palmer, 2010, Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease, Ann Intern Med, 153, 23, 10.7326/0003-4819-153-1-201007060-00252 Ye, 2018, Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials, Ren Fail, 40, 671, 10.1080/0886022X.2018.1532909 McMurray, 2012, Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease, Kidney Int Suppl, 2, 279 Locatelli, 2013, Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement, Nephrol Dial Transplant, 28, 1346, 10.1093/ndt/gft033 Yamamoto, 2017, 2015 Japanese Society for Dialysis Therapy: Guidelines for renal anemia in chronic kidney disease, Ren Replace Ther, 3, 36, 10.1186/s41100-017-0114-y Movilli, 2002, Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy, Am J Kidney Dis, 39, 850, 10.1053/ajkd.2002.32007 Minutolo, 2003, Intra- and post-dialytic changes of haemoglobin concentrations in non-anaemic haemodialysis patients, Nephrol Dial Transplant, 18, 2606, 10.1093/ndt/gfg387 Bellizzi, 2002, Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients, Am J Kidney Dis, 40, 549, 10.1053/ajkd.2002.34913 Toida, 2017, Relationship between hemoglobin levels corrected by interdialytic weight gain and mortality in Japanese hemodialysis patients: Miyazaki Dialysis Cohort Study, PLoS One, 12, 10.1371/journal.pone.0169117 Young, 2000, The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study, Kidney Int, 57, S74, 10.1046/j.1523-1755.2000.07413.x Pisoni, 2004, The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology, Am J Kidney Dis, 44, 7, 10.1016/S0272-6386(04)01099-6 Saran, 2003, Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS, Kidney Int, 64, 254, 10.1046/j.1523-1755.2003.00064.x Wang, 2016, Association between changes in CMS reimbursement policy and drug labels for erythrocyte-stimulating agents with outcomes for older patients undergoing hemodialysis covered by fee-for-service Medicare, JAMA Intern Med, 176, 1818, 10.1001/jamainternmed.2016.6520 Go, 2004, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 351, 1296, 10.1056/NEJMoa041031 Kurita, 2017, Revisiting interdialytic weight gain and mortality association with serum albumin interactions: the Japanese Dialysis Outcomes and Practice Pattern Study, J Ren Nutr, 27, 421 Yokoyama, 2017, Ferritin elevation and improved responsiveness to erythropoiesis-stimulating agents in patients on ferric citrate hydrate, Kidney Int Rep, 2, 359, 10.1016/j.ekir.2016.12.005 Fishbane, 2007, Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets, Clin J Am Soc Nephrol, 2, 1274, 10.2215/CJN.02380607 VanderWeele, 2014, A tutorial on interaction, Epidemiol Methods, 3, 33, 10.1515/em-2013-0005 Rothman, 2012, 198 van Buuren, 1999, Multiple imputation of missing blood pressure covariates in survival analysis, Stat Med, 18, 681, 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R Kalantar-Zadeh, 2009, Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis, Circulation, 119, 671, 10.1161/CIRCULATIONAHA.108.807362 Kalantar-Zadeh, 2003, Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients, Am J Kidney Dis, 42, 761, 10.1016/S0272-6386(03)00915-6 Honda, 2006, Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD, Am J Kidney Dis, 47, 139, 10.1053/j.ajkd.2005.09.014 Weiner, 2014, Improving clinical outcomes among hemodialysis patients: a proposal for a “volume first” approach from the chief medical officers of US dialysis providers, Am J Kidney Dis, 64, 685, 10.1053/j.ajkd.2014.07.003